Leveraged finance
Singapore's Quadria secures $200m 'social' credit facility
Singapore-based healthcare specialist Quadria Capital has secured a revolving credit facility of up to USD 200m for investments deemed “social projects.”
PE-owned Japanese drug maker seeks bankruptcy protection
Kyowa Pharmaceutical Industry, a Japanese generic drug manufacturer owned by Unison Capital, has applied for alternative dispute resolution, an out-of-court process that allows companies to continue operations while negotiating with creditors on a restructuring....
Asia deal financing: A selective market
Regional buyout activity is weak but leveraged loans are available for the right kind of target – in Japan, Korea, Australia, and beyond – and with a suitably customised structure
Australia's GenesisCare files for US bankruptcy protection
GenesisCare, an Australia-headquartered cancer care provider in which KKR holds a minority stake, has filed for bankruptcy protection in the US and announced a restructuring that will separate US operations from those in Australia, Spain, and the UK....
Australia's Real Pet Food taps investors for equity injection
Hosen Capital, New Hope Group, and Temasek Holdings have led a AUD 248m (USD 161.2m) equity injection into Australia-based chilled pet food supplier Real Pet Food to pay down debt and support growth.
BPEA EQT seeks financing for Vistra, Tricor merger
BPEA EQT is pushing ahead with the merger of Asia-headquartered corporate services providers Vistra Group and Tricor Group, having initiated discussions on pricing a USD 1.66bn financing package.
Deal focus: GL Capital plots careful China carve-out
GL Capital worked quietly but industriously to secure a leveraged buyout of China-based contract manufacturer Foryou Medical Devices – even using renminbi financing to avoid US dollar interest rate exposure
GPs double down on value creation to maintain returns - AVCJ Forum
Private equity investors must find more operational levers to pull as LPs seek the same if not higher returns from the asset class despite more challenging economic conditions.
Q&A: Bain Capital's David Gross-Loh
David Gross-Loh, a managing director and a founding member of the Asia business at Bain Capital, on expanding into Osaka, targeting large-cap carve-outs in Japan, and the availability of deal financing
Deal financing: Homegrown solutions
Private equity firms are relying more heavily on Asia-based debt investors to support leveraged buyouts amid a loan logjam in the US, highlighting the region’s innovation and durability
Australia take-privates: Going large
A combination of abundant dry powder and friendly financing conditions are encouraging global GPs to pursue ever-larger listed companies in Australia. For now, macro headwinds are no deterrent
Leveraged finance: ESG sells
Private equity firms in Asia are increasingly willing to consider sustainability-linked credit facilities, and banks are generally happy to provide them. Speed is currently delaying standardisation
Baring Asia completes $386m recap of CitiusTech
Baring Private Equity Asia (BPEA) has completed a USD 385.9m dividend recap and refinancing of loans tied to its 2019 acquisition of India-based healthcare IT services business CitiusTech.
TPG-owned clinical trials player raises new equity, debt
Novotech, an Asia-based clinical trials specialist controlled by TPG Capital, has secured USD 760m in new equity and debt financing at a post-deal valuation of approximately USD 3bn.
Baring Asia creates sustainability-linked credit facility
Baring Private Equity Asia (BPEA) has secured a $3.2 billion loan to support its private equity platform with interest rate reductions linked to performance against a series of sustainability metrics.
Asia travel & hospitality: Ready to board?
The outlook for international tourism remains uncertain, but this hasn’t stopped some private equity and venture capital investors targeting travel and hospitality assets in Asia. It pays to be selective
Asia buyout returns: Spoilt for choice?
Fund managers believe the ability to finance and refinance deals on attractive terms, as well as a wider array of paths to liquidity, will underpin performance in Asia
Coronavirus & leverage: Room to maneuver?
Economic disruption caused by the coronavirus outbreak is likely to leave many private equity portfolio companies in breach of their leverage covenants. Borrowers and lenders are looking for a fix
Macro factors not slowing private debt in Australia - AVCJ Forum
Leveraged lenders focusing on Australia and New Zealand continue to see strong demand from financial sponsors, with the impact of global macroeconomic volatility likely to be delayed and perhaps muted.
LPs warn of impending downturn in Asia
Institutional investors are preparing for a downturn in Asia – and emphasizing the importance of disciplined deployment – as they see worrying “pro-cycle market behavior” in the private markets space globally.
Blackstone completes dividend recap of India's Mphasis
Indian IT services provider Mphasis has issued $500 million in bonds, the proceeds of which will be used to recapitalize its debt and make a dividend payment to majority owners The Blackstone Group and GIC Private.
Australia mezzanine: Compromise solution
The rise of holdco PIK debt has created Australia-based financing structures in which senior lenders and mezzanine providers can coexist. They also offer GPs greater flexibility at what is, for now, an acceptable price
KKR-owned MMI completes $580m refinancing
MMI, a Singapore-based hard disk drive components manufacturer owned by KKR, has secured a $520 million term loan and a $60 million five-year secured revolving credit facility to refinance its outstanding debt.